New paper by Dr. Dan Høgdall in Clinical Cancer Research

New paper by Dr. Dan Høgdall, MD PhD in Clinical Cancer Research: 

Serum IL-6 as a prognostic biomarker and IL-6R as a therapeutic target in biliary tract cancers